TALZENNA is a medication specifically designed for adult patients who have deleterious or suspected deleterious germline breast cancer susceptibility gene (BRCA)-mutated (gBRCAm) human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer. It is important to note that TALZENNA is not intended for use in patients with germline BRCA mutations who have received previous chemotherapy. If you or someone you know meets the criteria for TALZENNA treatment, it is recommended that you speak with your healthcare provider to determine if this medication is right for you.
We are a leading manufacturer and exporter of oncology drugs and anticancer drugs in Vietnam. Our products are carefully formulated and manufactured using the latest technology and highest quality standards. Our team of experienced scientists and researchers work tirelessly to develop innovative and effective treatments that can improve the lives of patients.